Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Redwood AI's CEO says their AI platform speeds drug discovery by analyzing chemical reactions for safety, cost, and environmental impact.
Redwood AI CEO Louis Dron discussed the company’s AI-driven chemistry platform on *Conversations That Matter*, a British Columbia television program, explaining how it uses artificial intelligence and large-scale reaction data to accelerate drug discovery by helping chemists evaluate manufacturing pathways, costs, safety, and environmental impact.
The platform aims to streamline the screening of vast compound libraries, a major challenge in pharmaceutical development.
Dron also highlighted its potential applications in defense, environmental science, materials research, and agriculture, including chemical threat screening and supply chain assessments.
The system supports secure, local deployment—even in air-gapped environments—protecting data sovereignty and intellectual property.
El CEO de Redwood AI dice que su plataforma de IA acelera el descubrimiento de medicamentos mediante el análisis de reacciones químicas para la seguridad, el costo y el impacto ambiental.